Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

NCT01368757 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myelomonocytic Leukemia

Interventions

DRUG: Revlimid

Sponsor

Arbeitsgemeinschaft medikamentoese Tumortherapie

Collaborators

[object Object]